Stay updated with breaking news from Jared Maxwell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Just when what we were all wishing for was a return to normal in 2021, the NRL throw a set of rule changes at us. Graham Annesley, fresh from surviving the drastic slimming down at NRL HQ, has announced eight shifts to keep us all on our toes. The NRL’s public mouthpiece – also referred […]
NRL head of football discusses rule changes
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key ... Myriad Genetics, Inc.February 18, 2021 GMT SALT LAKE CITY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new technology and healthcare leaders who recently joined the company as well as key promotions to drive critical business functions, transformation and growth initiatives. “With the addition of new lea...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad ... Myriad Genetics, Inc.February 12, 2021 GMT SALT LAKE CITY, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced today additional data further validating the prognostic power of its Prolaris® test and its ability to help accurately predict which men with more aggressive prostate cancer will benefit from intensification of ther...
Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in Japan Font : A-A+ from Treatment with Lynparza More Than 20,000 Patients in Japan Now Qualify for Genetic Testing SALT LAKE CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- In an announcement that will help more people with advanced prostate and pancreatic cancers in Japan, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will receive reimbursement for its BRACAnalysis ® Diagnostic System, which helps physicians determine whether certain patients will qualify and potentially bene...